Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A Dose Response and Safety Study of Procaine HCl in HIV-Infected Patients

This study has been completed.
Information provided by:
Samaritan Pharmaceuticals, Inc Identifier:
First received: March 2, 2006
Last updated: March 31, 2006
Last verified: March 2006
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: September 2001
  Estimated Primary Completion Date: No date given